A multi-institutional team developed a chimeric antigen receptor (CAR) T cell-based strategy for specifically targeting AML cells in patients who relapsed following other treatments. The team ...

Exicure, Inc. (Nasdaq: XCUR) today shared updates on its lead asset, GPC-100 (burixafor), a small molecule CXCR4 inhibitor. Exicure, Inc. ("Exicure") is planning for a clinical trial in Acute Myeloid ...

Omeros forms oncology committee to guide development of its AML therapy, which showed strong efficacy and safety in ...

11, 2025 — A multi-institutional team developed a chimeric antigen receptor (CAR) T cell-based ... to effectively kill acute myeloid leukemia ... Novel Bone Marrow Transplant Can Cure Sickle ...

Orca-T showed lower rates of graft-vs-host disease or infection compared with allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome (MDS) or acute leukemias in the ...

A Ludwig Cancer Research study has identified a novel strategy for treating acute myelogenous leukemia (AML), an aggressive ...

A Ludwig Cancer Research study has identified a novel strategy for treating acute myelogenous leukemia (AML), an aggressive blood cancer for which the median survival time following diagnosis remains ...

Amanda Faulkner, who had always considered herself healthy and active, was shocked to discover she had acute myeloid ...

A Winnipeg couple has temporarily relocated to Memphis, Tennessee, in search of lifesaving treatment for their 3-year-old son ...

The family of a young boy fighting cancer spoke with WMBF News on Sunday after finding out the seven-year-old is cancer-free.

Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) recently completed a listing agreement with the provincial government of ...